Jay Shubrook reflects on a case concerning a patient who came into his clinic after taking a 'diabetes holiday' and discusses some of the practical ways in which you might prevent such holidays in your patients.

Less than one-third of patients with type 2 diabetes and cardiovascular disease are receiving optimal care for secondary prevention of cardiovascular events, suggests an analysis of data from the TECOS trial.

Cochrane reviewers have assessed the effectiveness of behavior-changing interventions in overweight and obese children, finding an indication of benefit but based on mostly low-quality evidence.

Analysis of gene expression changes underlying excess glucose production in the liver has identified a drug – derived from broccoli – with a mechanism of action complementary to that of metformin.

The 2015 Global Burden of Disease study shows that the prevalence of obesity continues to rise, adding to the burden of obesity-related mortality.

Comment on: Racial and individual variability in HbA1c–glucose relationship